GRIFOLS ENGINEERING – LIBERIA
Grifols Engineering produces modular test centers for Liberia
Grifols Engineering, together with the Probitas Foundation, has begun the installation of new modular centers in Liberia to produce anti-Ebola immunoglobulins.
The purpose of these modules is to centralize the testing of samples from donors who have recovered from Ebola, to improve the process and the gathering of results. The samples obtained will be tested using the PCR technique (Polymerase Chain Reaction), which is used to amplify DNA sequences.
New modular centers
The new centers are organized into two independent areas: the PCR tests for detecting Ebola and Lassa fever will be carried out in the first, and HIV and hepatitis B and C in the second.
Grifols Engineering has carried out 100% of the design and the construction of the new modules, resulting in a significant improvement in the thermal insulation features and climate elements. The modules also incorporate solar panels and other elements to guarantee the sustainability of the facility.
Two years after launching the project in 2014 the company established the first modular plasma donor center in Monrovia to collect plasma from donors who had survived the disease.
Since Grifols reached an agreement with the Government of the Republic of Liberia, Grifols Engineering has continued strengthening the project's key elements, such as improving the design of the modular centers, always adhering to the highest standards of quality.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?